Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)

NCT01902953 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer
Rectal Cancer

Interventions

DRUG: Lymphoseek and VBD Sln dissection

Sponsor

Maimonides Medical Center